new_0222_0604|PSTX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0604|PSTX|1|Poseida Therapeutics Inc Total Current Assets (Quarterly) (USD)|Poseida Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Poseida Therapeutics Inc Inventories (Quarterly) (USD)|Poseida Therapeutics Inc Net PP&E (Quarterly) (USD)|Poseida Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Poseida Therapeutics Inc Total Liabilities (Quarterly) (USD)|Poseida Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Poseida Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Poseida Therapeutics Inc Total Deposits (Quarterly) (USD)|Poseida Therapeutics Inc Book Value (Quarterly) (USD)|Poseida Therapeutics Inc Retained Earnings (Quarterly) (USD)|Poseida Therapeutics Inc Treasury Stock (Quarterly) (USD)|Poseida Therapeutics Inc EV to Revenues|Poseida Therapeutics Inc EV to Earnings|Poseida Therapeutics Inc EV to Free Cash Flow|Poseida Therapeutics Inc EV to Assets (Quarterly)|Poseida Therapeutics Inc PS Ratio|Poseida Therapeutics Inc PE Ratio|Poseida Therapeutics Inc Price to Book Value|Poseida Therapeutics Inc PEG Ratio|Poseida Therapeutics Inc Debt to Equity Ratio|Poseida Therapeutics Inc Dividend Yield|Poseida Therapeutics Inc Shareholder Yield (TTM)|Poseida Therapeutics Inc Percent of Shares Outstanding Short|Poseida Therapeutics Inc Total Receivables (Quarterly) (USD)|Poseida Therapeutics Inc Total Payables (Quarterly) (USD)|Poseida Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Poseida Therapeutics Inc Return on Invested Capital|Poseida Therapeutics Inc Quality Ratio Score|Poseida Therapeutics Inc Momentum Score|Poseida Therapeutics Inc Beta (1Y)|Poseida Therapeutics Inc Sustainable Growth Rate (TTM)|Poseida Therapeutics Inc Institutional Investor Ownership Percentage|Poseida Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Poseida Therapeutics Inc Total Employees (Annual)|Poseida Therapeutics Inc EPS Diluted (Quarterly) (USD)|Poseida Therapeutics Inc Shares Outstanding|Poseida Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Poseida Therapeutics Inc Ordinary Shares Number (Quarterly)|Poseida Therapeutics Inc Payout Ratio|Poseida Therapeutics Inc Quick Ratio (Quarterly)|Poseida Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Poseida Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Poseida Therapeutics Inc Effective Tax Rate (TTM)|Poseida Therapeutics Inc Return on Equity|Poseida Therapeutics Inc Net Income (TTM) (USD)|Poseida Therapeutics Inc Revenue (TTM) (USD)|Poseida Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Poseida Therapeutics Inc Revenue (Quarterly) (USD)|Poseida Therapeutics Inc Gross Profit (Quarterly) (USD)|Poseida Therapeutics Inc SG&A Expense (Quarterly) (USD)|Poseida Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Poseida Therapeutics Inc Net Income (Quarterly) (USD)|Poseida Therapeutics Inc Net Interest Income (Quarterly) (USD)|Poseida Therapeutics Inc Price (USD)|Poseida Therapeutics Inc Total Return Price (USD)|Poseida Therapeutics Inc Enterprise Value (USD)|Poseida Therapeutics Inc 30-Day Average Daily Volume|Poseida Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0604|PSTX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0604|PSTX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0604|PSTX|5|91.2857142857|91.2857142857||91.2857142857|91.2857142857|91.2857142857|91.2857142857|91.2857142857||91.2857142857|91.2857142857||||1.44581280788||||1.44571428571|||1.44581280788||15.2702702703||91.2857142857|91.2857142857|||30.6|30.6666666667||30.5|91.4|91.3333333333|91.4|34.7857142857||91.2857142857|||91.4|91.375|91.2857142857||91.2857142857|||||91.4|91.4|91.4|91.4|1.44471744472|1.44471744472|1.44581280788|1.44827586207|1.42857142857||
new_0222_0604|PSTX|6|7|7||7|7|7|7|7||7|7||||406||||350|||406||37||7|7|||5|6||14|10|6|10|14||7|||10|8|7||7|||||10|10|10|10|407|407|406|377|154||
new_0222_0604|PSTX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0604|PSTX|201903||||||||||||||||||||||||||||||||||39.7339||-0.3356||||||-0.3808|||||||||6.399|-13.334|-13.334|-0.795|||||||
new_0222_0604|PSTX|201906||||||||||||||||||||||||||||||||||39.7339||-0.7205||||||-0.5337|||||||||4.042|-28.627|-28.627|-0.903|||||||
new_0222_0604|PSTX|201909||||||||||||||||||||||||||||||||||39.7339||-0.5274||||||-0.5007|||||||||4.007|-20.954|-20.954|-0.935|||||||
new_0222_0604|PSTX|201912|127.179|125.318||10.858|5.548|296.507|21.855|274.652||-149.511|-152.221|||||||||||||||4.929|0.002|||||||39.7339||-0.5943|||57.8159|||-0.5943||||-86.528|||||4.008|-23.613|-23.613|-0.92|||||||
new_0222_0604|PSTX|202003|108.597|103.379||38.49|5.548|109.258|39.853|69.405||47.043|-180.894|||||||||||||||7.704|0.005|||||||57.8159|149|-0.4979|||57.8159|||-0.4979||||-101.978|||||4.854|-28.784|-28.784|-0.914|||||||
new_0222_0604|PSTX|202006|173.146|167.131||42.23|5.548|431.655|28.892|402.763||-205.303|-211.322||||-6.3515|||||||||1.005||1.562|0.002|||||||57.8159|156|-0.5263|61.8159||57.8159|||-0.5263||||-103.779|||||4.236|-30.428|-30.428|-0.892|12.98|12.98|664.2294|527470.3333||9.39|
new_0222_0604|PSTX|202009|347.277|341.457||48.798|5.548|109.335|29.77|79.565||295.836|-245.736||||-2.0389||||1.8535|||||1.8617||1.256|0.006||||||91.9618|54.9738|186|-0.63|61.8195||61.8195|||-0.63|-205.743|||-117.239|||||6.458|-34.414|-34.414|-0.848|8.87|8.87|235.941|405223.3333||11.51|11.61
new_0222_0604|PSTX|202012|313.996|309.152||48.322|5.548|109.516|30.025|79.491||261.968|-281.885||||-3.0606||||2.5904|||||2.3489||0.763|0.006||||||95.2223|61.8609|206|-0.58|61.8609||61.8609|||-0.58||||-129.774|||||7.476|-36.148|-36.148|-0.852|10.97|10.97|398.5951|198376||8.7|11.04
new_0222_0604|PSTX|202103|273.996|269.96||50.175|5.548|105.851|27.789|78.062||227.486|-320.199||||-2.4591||||2.6081|||||6.063||2.487|0.006|||||||61.9811|208|-0.62|62.1267||62.1267|||-0.62||||-139.304|||||8.369|-38.314|-38.314|-0.838|9.55|9.55|352.558|550772.7||9.36|8.45
new_0222_0604|PSTX|202106|240.372|237.261||49.365|5.548|112.535|31.999|80.536||186.576|-365.904||||-3.0331||||3.3386|||||4.5427||4.506|0.006|||2|-0.9434|||62.151|220|-0.74|62.1662||62.1662|||-0.74||||-154.581|||||8.871|-45.705|-45.705|-0.843|10.02|10.02|414.9173|258245.1333|-39.1598|8.11|8.64
new_0222_0604|PSTX|202109|204.799|197.811||47.629|5.548|111.78|31.797|79.983||150.157|-408.328||||-1.9664||||3.0329|||||2.2932||3.644|0.006|||5|0.1475||91.6726|62.2982|254|-0.68|62.4698||62.4698|||-0.68||||-162.591|||||9.066|-42.424|-42.424|-0.837|7.29|7.29|286.9078|210574.8667|-17.8129|6.41|6.95
new_0222_0604|PSTX|202112|||||||||||||||-1.7626||||2.8348|||||1.0466||||||2|0.752||90.0904||||||||||||||||||||||6.81|6.81|257.1709|153996.0333|-37.9216|4.75|3.97